Evidence map›Paper›PMID 38918786›Full record

ArticleBMC cancer2024

A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension.

Jia-Zhou Ye, Hua-Ze Lu, Can Zeng, Guo Lei, Xiao-Bo Wang, Jie Chen, Tao Bai, Fei-Xiang Wu, Rong-Yun Mai, Wei-Xing Guo and 1 more

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jia-Zhou Ye *Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.
Hua-Ze Lu *Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.
Can ZengDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.
Guo LeiDepartment of Hepatic Suegery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200438, China.
Xiao-Bo WangDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.
Jie ChenDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.
Tao BaiDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.
Fei-Xiang WuDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.
Rong-Yun MaiDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China. mairongyun@sr.gxmu.edu.cn.
Wei-Xing GuoDepartment of Hepatic Suegery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200438, China. weixingg@126.com.
Le-Qun LiDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, China. lequn_li001@163.com.

Funding

Nanning Qingxiu District Science and Technology Project No. 2021010Project for Enhancing Young and Middle-aged Teacher's Research Basis Ability in Colleges of Guangxi NO. 2024KY0133Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital NO.2023-7
6 · The paper itself

Abstract

objectiveClinically significant portal hypertension (CSPH) seriously affects the feasibility and safety of surgical treatment for hepatocellular carcinoma (HCC) patients. The aim of this study was to establish a new surgical scheme defining risk classification of post-hepatectomy liver failure (PHLF) to facilitate the surgical decision-making and identify suitable candidates for individual hepatectomy among HCC patients with CSPH. BACKGROUNDS: Hepatectomy is the preferred treatment for HCC. Surgeons must maintain a balance between the expected oncological outcomes of HCC removal and short-term risks of severe PHLF and morbidity. CSPH aggravates liver decompensation and increases the risk of severe PHLF thus complicating hepatectomy for HCC.

methodsMultivariate logistic regression and stochastic forest algorithm were performed, then the independent risk factors of severe PHLF were included in a nomogram to determine the risk of severe PHLF. Further, a conditional inference tree (CTREE) through recursive partitioning analysis validated supplement the misdiagnostic threshold of the nomogram.

resultsThis study included 924 patients, of whom 137 patients (14.8%) suffered from mild-CSPH and 66 patients suffered from (7.1%) with severe-CSPH confirmed preoperatively. Our data showed that preoperative prolonged prothrombin time, total bilirubin, indocyanine green retention rate at 15 min, CSPH grade, and standard future liver remnant volume were independent predictors of severe PHLF. By incorporating these factors, the nomogram achieved good prediction performance in assessing severe PHLF risk, and its concordance statistic was 0.891, 0.850 and 0.872 in the training cohort, internal validation cohort and external validation cohort, respectively, and good calibration curves were obtained. Moreover, the calculations of total points of diagnostic errors with 95% CI were concentrated in 110.5 (range 76.9-178.5). It showed a low risk of severe PHLF (2.3%), indicating hepatectomy is feasible when the points fall below 76.9, while the risk of severe PHLF is extremely high (93.8%) and hepatectomy should be rigorously restricted at scores over 178.5. Patients with points within the misdiagnosis threshold were further examined using CTREE according to a hierarchic order of factors represented by the presence of CSPH grade, ICG-R15, and sFLR.

conclusionThis new surgical scheme established in our study is practical to stratify risk classification in assessing severe PHLF, thereby facilitating surgical decision-making and identifying suitable candidates for individual hepatectomy.

Indexed as

Carcinoma, HepatocellularHepatectomyHypertension, PortalLiver NeoplasmsNomogramsAdultAgedFemaleHumansLiver FailureMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesRisk FactorsConditional inference treeHepatocellular carcinomaNomogramPortal hypertensionPost-hepatectomy liver failure

Identifiers

PMID38918786
PMCPMC11202348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.